Lakefront Biotherapeutics (LKFT) Accumulated Expenses (2014 - 2025)
Lakefront Biotherapeutics (LKFT) reported Accumulated Expenses of $23280.9 for Q4 2025, down 98.0% year-over-year from $1.2 million in Q4 2024, and down 98.0% quarter-over-quarter from $1.2 million in Q4 2024.
Lakefront Biotherapeutics (LKFT) Accumulated Expenses (2014 - 2025) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 8 years of Accumulated Expenses data on file, last reported at $23280.9 in Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $23280.9, down 98.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $23280.9 (down 98.0% YoY), and the FY2025 annual result was $23280.9, down 98.0% from the prior year.
- Accumulated Expenses fell to $23280.9 in Q4 2025 per LKFT's latest filing, from $1.2 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $1.2 million in Q4 2024 and troughed at $23280.9 in Q4 2025.
- A 3-year average of $593267.4 and a median of $589615.1 in 2023 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses surged 97.91% in 2024, then slumped 98.0% in 2025.
- A 3-year view of Accumulated Expenses shows it stood at $589615.1 in 2023, then surged by 97.91% to $1.2 million in 2024, then tumbled by 98.0% to $23280.9 in 2025.
- Business Quant data shows LKFT's Accumulated Expenses at $23280.9 in Q4 2025, $1.2 million in Q4 2024, and $589615.1 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23,280.87 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 589,615.07 |
| Sep 30, 2018 | 1.01 Mn |
| Jun 30, 2018 | 1.03 Bn |
| Mar 31, 2018 | 1.16 Mn |
| Dec 31, 2017 | 1.36 Mn |
| Jun 30, 2017 | 1.15 Mn |
| Mar 31, 2017 | 981,239.75 |
| Dec 31, 2016 | 668,349.29 |
| Jun 30, 2016 | 813,510.02 |
| Dec 31, 2015 | 537,097.47 |
| Dec 31, 2014 | 731,152.59 |